The second Golrang Pharmaceutical and Health Innovation Event was held on December 29, 2025 (8 Azar 1404), with the participation of Golrang judges and experts, aiming to review and evaluate 9 innovative product projects in the pharmaceutical and healthcare fields. The projects evaluated at this event successfully passed this stage and entered various collaboration pathways with Golrang Pharmaceutical Investment Company and Golrang Ventures.
According to the Public Relations Office of Golrang Pharmaceutical Group, during the fall of 2025, the Golrang Pharmaceutical and Health Innovation Center received a total of 40 project proposals through different channels (30 projects from the Iran Pharma Exhibition and 10 projects from a nanomedicine startup event).
In the first stage, all submitted projects underwent an initial screening and preliminary evaluation process. In the second stage, selected projects advanced to the presentation phase before the judges and entered the investment attraction process. The objective of this evaluation was to identify projects that stand out in terms of technical feasibility, innovation, alignment with the strategic goals of Golrang Industrial Group, market potential, and economic scalability, and that demonstrate added value for progressing to the investment and financial support stage.
The projects presented covered a wide range of areas within the pharmaceutical and healthcare industry. The main focus areas included advanced formulation technologies for chemical drugs, pharmaceutical and health supplements, development of active pharmaceutical ingredients (APIs), innovative wound care solutions, and medical consumable devices.
This program was implemented within the framework of Golrang Pharmaceutical Group’s mission to empower the innovation ecosystem, support strategic health technologies, and strengthen the country’s knowledge-based capabilities. Similar events and programs will continue to be held on a regular basis.
